Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Tomohiro Kotaki"'
Autor:
Siti Qamariyah Khairunisa, Dwi Wahyu Indriati, Ni Luh Ayu Megasari, Shuhei Ueda, Tomohiro Kotaki, Muhamad Fahmi, Masahiro Ito, Brian Eka Rachman, Afif Nurul Hidayati, Nasronudin, Masanori Kameoka
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Human immunodeficiency virus type 1 (HIV-1) remains a serious health threat in Indonesia. In particular, the CRF01_AE viruses were the predominant HIV-1 strains in various cities in Indonesia. However, information on the dynamic transmission
Externí odkaz:
https://doaj.org/article/60944b4ee96e40fbbe6352fde8cb0485
Autor:
Brian Eka Rachman, Ni Luh Ayu Megasari, Siti Qamariyah Khairunisa, Tomohiro Kotaki, M Vitanata Arfijanto, Usman Hadi, Nasronudin Nasronudin, Masanori Kameoka
Publikováno v:
Acta Medica Indonesiana, Vol 56, Iss 2 (2024)
Background: Despite the availability of various effective antiretroviral (ARV) drugs, human immunodeficiency virus (HIV) infection has come with HIV drug resistance (HIVDR), which compromises its effectiveness in reducing HIV-related morbidity, morta
Externí odkaz:
https://doaj.org/article/9f2eef50cb3d4e93ad2fd5a1111eea85
Autor:
Shohei Minami, Tomohiro Kotaki, Yusuke Sakai, Shinya Okamura, Shiho Torii, Chikako Ono, Daisuke Motooka, Rina Hamajima, Ryotaro Nouda, Jeffery A. Nurdin, Moeko Yamasaki, Yuta Kanai, Hirotaka Ebina, Yusuke Maeda, Toru Okamoto, Taro Tachibana, Yoshiharu Matsuura, Takeshi Kobayashi
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 4 (2024)
ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes several host proteases to cleave the spike (S) protein to enter host cells. SARS-CoV-2 S protein is cleaved into S1 and S2 subunits by furin, which is closely involved in t
Externí odkaz:
https://doaj.org/article/52bcfaa75fde4976b2cff269b2a83cf6
Autor:
Shohei Minami, Naomi Matsumoto, Hiroko Omori, Yutaka Nakamura, Shigeyuki Tamiya, Ryotaro Nouda, Jeffery A. Nurdin, Moeko Yamasaki, Tomohiro Kotaki, Yuta Kanai, Toru Okamoto, Taro Tachibana, Hiroshi Ushijima, Takeshi Kobayashi, Shintaro Sato
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe acute respiratory symptoms in humans. Controlling the coronavirus disease pandemic is a worldwide priority. The number of SARS-CoV-2 studies has dramatically increase
Externí odkaz:
https://doaj.org/article/87258b246f2a436185b38dcf74f2a65a
Publikováno v:
Virus Research, Vol 334, Iss , Pp 199176- (2023)
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has necessitated the global development of countermeasures since its outbreak. However, current therapeutics and vaccines to sto
Externí odkaz:
https://doaj.org/article/006110d1699d4c3c819b3154db1eb98d
Autor:
Tomohiro Kotaki, Takeshi Kurosu, Ariadna Grinyo-Escuer, Edgar Davidson, Siti Churrotin, Tamaki Okabayashi, Orapim Puiprom, Kris Cahyo Mulyatno, Teguh Hari Sucipto, Benjamin J. Doranz, Ken-ichiro Ono, Soegeng Soegijanto, Masanori Kameoka
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Dengue virus (DENV), from the genus flavivirus of the family flaviviridae, causes serious health problems globally. Human monoclonal antibodies (HuMAb) can be used to elucidate the mechanisms of neutralization and antibody-dependent enhancem
Externí odkaz:
https://doaj.org/article/b08a284eec634976b8ba9f7d74a2d036
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract The development of specific antiviral compounds to SARS-CoV-2 is an urgent task. One of the obstacles for the antiviral development is the requirement of biocontainment because infectious SARS-CoV-2 must be handled in a biosafety level-3 lab
Externí odkaz:
https://doaj.org/article/14dcdbd4693243798f8fae9ed7bc5980
Autor:
Akina Nakamura, Tomohiro Kotaki, Yurie Nagai, Shunta Takazawa, Kenzo Tokunaga, Masanori Kameoka
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global threat. To forestall the pandemic, developing safe and effective vaccines is necessary. Because of the rapid
Externí odkaz:
https://doaj.org/article/cc887e63b6944871b219c923b543a453
Autor:
Masahiro Urushidani, Akira Kawayoshi, Tomohiro Kotaki, Keiichi Saeki, Yasuko Mori, Masanori Kameoka
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0261802 (2022)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is transmitted mainly by droplet or aerosol infection; however, it may also be transmitted by contact infection. SARS-CoV-2 that
Externí odkaz:
https://doaj.org/article/fc51db03ff024ef5af97121a70d6fea7
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1411 (2022)
Infection with viruses belonging to the genus Flavivirus, such as Japanese encephalitis virus (JEV) and dengue virus (DENV), is a worldwide health problem. Vaccines against JEV and DENV are currently available. However, the dengue vaccine possibly in
Externí odkaz:
https://doaj.org/article/2991af9e7c884ea6b6a3be6d76fc6d8d